Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#

TLDR

Anemia is a common complication and frequent comorbidity of inflammatory bowel disease that leads to hospitalization and delays discharge, necessitating focused attention and care. The authors formed an international working party to develop guidelines for evaluating and treating anemia and iron deficiency in inflammatory bowel disease for gastroenterologists. The guidelines comprise 16 statements detailing diagnostic screening for iron and other anemia-related deficiencies, criteria for initiating treatment, therapeutic goals, and appropriate therapies.

Abstract

Anemia is a common complication of inflammatory bowel diseases. An international working party has formed and developed guidelines for evaluation and treatment of anemia and iron deficiency that should serve practicing gastroenterologists. Within a total of 16 statements, recommendations are made regarding diagnostic measures to screen for iron- and other anemia-related deficiencies regarding the triggers for medical intervention, treatment goals, and appropriate therapies. Anemia is a common cause of hospitalization, prevents physicians from discharging hospitalized patients, and is one of the most frequent comorbid conditions in patients with inflammatory bowel disease. It therefore needs appropriate attention and specific care.